Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
50-65-7
Molecular formula
C13H8Cl2N2O4
Molecular weight
327.12 g/mol
Drug class
Salicylanilide anthelminticcestocidal agent
Mechanism of action
Interferes with mitochondrial energy metabolism and oxidative phosphorylation in cestodes, disrupting ATP production and causing death of the parasite. It is poorly absorbed from the gastrointestinal tract.
Indications / reported uses
Treatment of intestinal tapeworm infections (taeniasis) caused by susceptible cestodes in countries where oral niclosamide is authorised; it is not a treatment for tissue-invasive larval tapeworm disease
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Niclosamide PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Niclosamide Permitted Daily Exposure (PDE) report (the Niclosamide PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Niclosamide Occupational Exposure Limit (OEL) report (the Niclosamide OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.